510(k) Report

510(k) · Cleared

Cleared

Jada System

K212757510(k) SpecialCleared Sep 30, 202130-day reviewClass II21 CFR 884.4530

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Alydia Health · OQY Intrauterine Tamponade Balloon

Cleared on Sep 30, 2021 as substantially equivalent to K201199 (Alydia Health, 2020) after a 30-day review. Its family tree reaches back 4 generations to 2002. 1 later device descends from it.

Decided
Sep 30, 2021
Review
30 days
Class
Class II
Product code
OQY
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K013597 (2002). 1 later device descends from it, 1 citing it directly.

  1. Root · 4 generations backK013597 Tamponade Uterine Balloon Catheter SetCook Ob/Gyn · 2002
  2. 3 generations backK062438 Bakri Postpartum Balloon, Model J-Sos-100500Cook Ob/Gyn · 2006
  3. 2 generations backK170622 Bakri Postpartum Balloon, Bakri Postpartum Balloon with Rapid…Cook Incorporated · 2017
  4. 1 generation backK201199 Jada SystemAlydia Health · 2020
  5. This deviceK212757 Jada SystemAlydia Health · 2021
  6. Descendant · cites it directly · 0 of its ownK253642 Jada System (Jada-2002)Organon, LLC · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K253642Jada System (Jada-2002)Organon, LLC · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K013597Tamponade Uterine Balloon Catheter SetCook Ob/Gyn2002—
−3K062438Bakri Postpartum Balloon, Model J-Sos-100500Cook Ob/Gyn2006—
−2K170622Bakri Postpartum Balloon, Bakri Postpartum Balloon with Rapid Instillation…Cook Incorporated2017—
−1K201199Jada SystemAlydia Health2020—
0 (this device)K212757Jada SystemAlydia Health2021—
+1K253642Jada System (Jada-2002)Organon, LLC2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K212757, 2002–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OQY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OQY device

  1. #1 K253642 Jada System (Jada-2002)score 12.5 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K201199Jada System
Summary page 4
…21 CFR § 884.4530 Regulatory Class: II Product Code: OQY III. PREDICATE DEVICE The predicate device is the Jada System, K201199. This predicate has not been subject to a design-related recall. IV. DEVICE DESCRIPTION The subject of this submission is t…
Alydia Health2020—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K253642Jada System (Jada-2002)Organon, LLC20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 4.5 years on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K253642 (Organon, LLC, 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All OQY devices

OQY Intrauterine Tamponade Balloon: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · OQY

1in 2023

2010: 12011: 12015: 12016: 12017: 12019: 12020: 12021: 12022: 12023: 12026 (partial year): 1
2007high 1 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OQY

Too few OQY 510(k)s in any year since 2007 to give a median.

Recalls per year · OQY

1in 2015

2014: 12015: 1
2007high 1 (2014) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OQY

176in 2025

2011: 12013: 22014: 42015: 52016: 92017: 32018: 552019: 902020: 902021: 1132022: 2742023: 2282024: 2152025: 176
2007high 274 (2022) · low 0 (2007)2025

MAUDE reports naming product code OQY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20101—00
20111—01
20120—00
20130—02
20140—14
20151—15
20161—09
20171—03
20180—055
20191—090
20201—090
20211—0113
20221—0274
20231—0228
20240—0215
20250—0176
20261—0—

What is it indicated for?

The Jada® System is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K212757: Jada System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K212757

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026